Helius Medical Technologies, based in Newtown, Pennsylvania, focuses on neurological wellness and went public on June 27, 2014. Their product, PoNS, is a non-implantable device that treats gait and balance deficits.
HSDT has been in the news recently: HELIUS MEDICAL TECHNOLOGIES reported a 15% increase in revenue this quarter, indicating strong sales growth and market demand for their products. Meanwhile, U.S. stock futures were mixed, with Dow futures dropping about 0.1% following a day of record gains.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
